Quality of life in persons living with psoriasis patients

Martínez‐García, Eliseo; Arias‐Santiago, Salvador; Valenzuela-Salas, Ignacio; Garrido‐Colmenero, Cristina; García‐Mellado, Valentin; Buendía‐Eisman, A.

doi:10.1016/j.jaad.2014.03.039

Cited by 91 publications

(101 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In line with these results, the review discloses that the HRQoL of partners and relatives of psoriatic patients can be significantly affected. A recent study published in Spain confirmed these results, suggesting that psoriasis markedly reduces the global well-being of patients and their cohabitants, who experienced an impairment of their HRQoL and higher levels of anxiety and depression [40].…”

Section: Discussionmentioning

confidence: 61%

Health-related quality of life in patients with psoriasis: a systematic review of the European literature

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 61%

Health-related quality of life in patients with psoriasis: a systematic review of the European literature

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The global well-being of patients and their cohabitants, who experience impairment in QoL of patients and higher levels of anxiety and depression, is markedly worsened by Ps 27. Tezel et al28 studied 80 patients with PA, 40 patients with Ps and 40 healthy subjects in terms of QoL and functional status and found that patients with Ps and PA had worse QoL and patients with PA had worse functional status than healthy individuals.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis

Carneiro¹,

Chaves

Verardino

et al. 2017

CCID

View full text Add to dashboard Cite

BackgroundPsoriatic arthritis is associated with psychosocial morbidity and decrease in quality of life. Psychiatric comorbidity also plays an important role in the impairment of quality of life and onset of fatigue.ObjectivesThis study aimed to assess the prevalence of fatigue in psoriatic arthritis patients and to correlate it to quality of life indexes, functional capacity, anxiety, depression and disease activity.Patients and methodsThis cross-sectional study was performed on outpatients with psoriatic arthritis. Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-F; version 4) was used to measure fatigue; 36-Item Short Form Health Survey (SF-36) and Psoriasis Disability Index (PDI) to measure quality of life; Health Assessment Questionnaire (HAQ) to assess functional capacity; Hospital Anxiety and Depression (HAD) scale to measure anxiety and depression symptoms; Psoriasis Area and Severity Index (PASI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Clinical Disease Activity Index (CDAI) to evaluate clinical activity.ResultsIn all, 101 patients with mean age of 50.77 years were included. The mean PDI score was 8.01; PASI score, 9.88; BASDAI score, 3.59; HAQ score, 0.85; HAD – Anxiety (HAD A) score, 7.39; HAD Depression (HAD D) score, 5.93; FACIT–Fatigue Scale (FACIT-FS) score, 38.3 and CDAI score, 2.65. FACIT-FS was statistically associated with PASI (rs −0.345, p<0.001), PDI (rs −0.299, p<0.002), HAQ (rs −0.460, p<0.001), HAD A (rs −0.306, p=0.002) and HAD D (rs −0.339, p<0.001). The correlations with CDAI and BASDAI were not confirmed. There was statistically significant correlation with all of the domains of SF-36 and FACIT-F (version 4).ConclusionPrevalence of fatigue was moderate to intense in <25% of patients with psoriatic arthritis. Fatigue seems to be more related to the emotional and social aspects of the disease than to joint inflammatory aspects, confirming that the disease’s visibility is the most disturbing aspect for the patient and that “skin pain” is more intense than the joint pain.

show abstract

“…particularly severe disease, is associated with vascular disease 3,4 and vascular disease risk factors 5 such as metabolic syndrome, 6 smoking, 7,8 obesity, 9,10 depression, 11,12 diabetes mellitus, 13,14 and, importantly, excessive mortality. [15][16][17] In addition, either because of their disease or treatments they might have or had received, patients with psoriasis are at increased risk for certain other diseases such as cancers, including lymphoma and skin cancer, [18][19][20] and autoimmune diseases.…”

mentioning

confidence: 99%

Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasis

Gist¹,

Bhushan²,

Hamarstrom³

et al. 2015

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Quality of life in persons living with psoriasis patients

Cited by 91 publications

References 24 publications

Health-related quality of life in patients with psoriasis: a systematic review of the European literature

Health-related quality of life in patients with psoriasis: a systematic review of the European literature

Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis

Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasis

Contact Info

Product

Resources

About